RecruitingNCT06564779

Development, Standardisation and Standardisation Project for a New Memory Assessment

Sponsor

University Hospital, Tours

Enrollment

150 participants

Start Date

Nov 22, 2024

Study Type

OBSERVATIONAL

Conditions

Memory Disorders

Summary

Episodic memory (EM) is a neuropsychological marker of Alzheimer's disease (AD) (Thomas-Anterion, 2006). Current tests for its assessment do not take into account the identity and emotional aspects of memory (Van der Linden et al., 2018). However, there are models that integrate links with identity, self-awareness and experience. Pause et al. (2013) propose criteria to create ecological tools, including consideration of the emotional valence of memories and the spatio-temporal context of acquisition. In line with these criteria, we have developed a new tool: the NEM (New evaluation of Episodic Memory). Preliminary studies show different response profiles on the NEM among patients (Launay et al., 2023). We now want to evaluate the relevance of this tool in the differential diagnosis of AD.

Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and standardizing neuropsychological assessment tools — memory and thinking tests — specifically designed for people aged 50 and older who are showing early signs of memory problems (mild cognitive impairment). The goal is to create more reliable tests that clinicians across different centers can use consistently. **You may be eligible if...** - You are age 50 or older - You have been referred for a memory or cognitive assessment by your doctor - You have an amnesic (memory-based) mild cognitive impairment profile - You can understand and complete the assessments as judged by your evaluating clinician **You may NOT be eligible if...** - You have severe hearing or vision problems that would prevent you from completing cognitive tests - You are under legal guardianship or protected custody - You object to your data being used for research Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNew memory assessment

The intervention is part of the neuropsychological assessment carried out as part of routine care. It consists of carrying out the neuropsychological tests traditionally used to investigate the diagnostic hypothesis of Alzheimer's disease.